News
4317 posts · page 42 of 180
New MPN Treatments Transforming PV Nursing and Patient Care
Innovative therapies for myeloproliferative neoplasms (MPNs) are set to redefine nursing practices and patient care in polycythemia vera (PV).
Medtronic Raises 2027 Forecasts Amid Surging Heart Device Demand
Medtronic boosts 2027 revenue forecasts, driven by high demand for heart devices and strategic investments in medical technology.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in First Quarter Post-IPO
Molbio Diagnostics, newly listed on the stock exchange, posts Rs 52.7 crore profit in Q1, a turnaround from last year's loss.
Medtronic Raises 2027 Outlook Amid Surge in Heart Device Demand
Medtronic has increased its fiscal 2027 forecasts, driven by strong demand for heart devices and strategic investments in Pi-Cardia and Cornerstone Robotics.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics posts Rs 52.7 crore profit in Q1, reversing last year's loss, driven by Truenat test-kit demand.
Medtronic Raises 2027 Forecasts Amid Surge in Heart Device Demand
Medtronic boosts 2027 forecasts, fueled by strong demand for heart devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics, newly listed on the stock exchange, announces a Rs 52.7 crore profit for Q1, reversing last year's losses.
North Carolina Family Exposed to Rabid Goats at Petting Zoo
A mother in North Carolina speaks out after her family was exposed to rabies from goats at a petting zoo, prompting health officials to recommend treatment for over 250 people.
Medtronic Ups 2027 Forecasts Amid Rising Heart Device Demand
Medtronic projects higher fiscal 2027 revenue due to increased demand for heart devices and strategic investments.
Park Medi World to Launch 550-Bed Hospital in Prayagraj via New Subsidiary
Park Medi World establishes Park Medicity Prayagraj Ltd for a 550-bed hospital project under a PPP model with Prayagraj Municipal Corporation.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in First Quarter Post-IPO
Molbio Diagnostics posts Rs 52.7 crore profit in Q1, a sharp turnaround from last year's loss, driven by robust Truenat test-kit sales.
Challenges in Manufacturing Personalized Vaccines Despite Proven Efficacy
Personalized vaccines show promise in treatment, but production hurdles remain.
Northway Biotech Launches €61M Facility for Cell Therapy CDMO
Northway Biotech inaugurates a €61M facility focused on cell therapy and personalized medicine in Lithuania.
Iran's Genomic Diversity: Unveiling a Rich Genetic Tapestry
A comprehensive review highlights Iran's vast genetic diversity, offering insights into its potential impact on global health and personalized medicine.
10x Genomics Director Divests Over $1.2M in Company Shares
A director from 10x Genomics has sold shares exceeding $1.2 million, according to TradingView.
10x Genomics Director Stuelpnagel Sells $1.2 Million in Shares
10x Genomics board member Stuelpnagel divests $1.2 million in company stock, impacting market dynamics.
McKesson Pursues $2.25B Precision Medicine Acquisition Amid Rising Oncology Demand
McKesson is negotiating a $2.25 billion acquisition to enhance its oncology offerings, reflecting the sector's rapid growth.
AI and Precision Medicine: Revolutionizing Cancer Treatment
AI and precision medicine are transforming cancer care, offering personalized treatment and improved outcomes.
Inhibitory Neurons Offer New Hope in Adult Glioma Management
Recent research highlights the potential role of inhibitory neurons in controlling adult gliomas, offering new insights into brain cancer management.
Medtronic Projects Strong 2027 Growth Amid Heart Device Demand
Medtronic raises fiscal 2027 outlook, citing robust demand for heart devices and new investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics posts Rs 52.74 crore profit in Q1, reversing last year's loss, driven by Truenat test-kit sales.
Medtronic Increases 2027 Forecasts Amid Rising Heart Device Demand
Medtronic raises fiscal 2027 outlook due to strong heart device demand; invests in Pi-Cardia and Cornerstone Robotics.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics records Rs 52.7 crore profit in Q1, recovering from last year's loss, fueled by rising Truenat test-kit sales.
Nebraska Families Protest Medicaid Cuts for Disabled Residents
Nebraska reduces Medicaid for nearly 900 disabled residents, sparking family protests.